Kunac Desireé L, Reith David M
School of Pharmacy, University of Otago, Dunedin, New Zealand.
N Z Med J. 2008 Apr 18;121(1272):17-32.
To evaluate the frequency and characteristics of preventable medication-related events in hospitalised children, to determine the yield of several methods for identifying them and to recommend priorities for prevention.
A prospective observational cohort study was conducted over a 12-week period on the paediatric wards at a university-affiliated urban general hospital in New Zealand. For all admissions of greater than 24 hours, medication-related events were identified using a multifaceted approach and subsequently classified independently by three reviewers (using a standardised reviewer form) by event type, type of error, stage of the medication process, and preventability.
There were 495 eligible study patients, who had 520 admissions and 3037 patient days of admission, during which 3160 medication orders were written. Of 761 medication-related events reported during the study period, 630 (83.3%) were identified by chart review; 111 (14.6%) by a voluntary staff quality improvement reporting system; 16 (2.1%) by interview of parents; and 4 (0.53%) events via the concurrent routine hospital-incident reporting system. Excluding duplicate reports and practice-related issues, a total of 696 study patient-specific events were included in the analysis. Excluding the inconsequential events (trivial rule violation and 'other' categories), the majority [368/399 (92.2%)] of events were found to be preventable; comprising 38/67 (56.7%) ADEs, 75/77 (97.4%) potential ADEs, and all 255 (100%) harmless medication errors. Most commonly implicated in preventable ADEs and potential ADEs were, event rate (95%CI): improper dose and the prescribing stage-35 (29 to 42) and 74 (64 to 84) respectively per 1000 patient days; and antibacterial agents and the intravenous route of administration 21 (17 to 25) and 11 (10 to 13) respectively per 100 medication orders.
Preventable medication-related events occur commonly in the paediatric inpatient setting, and importantly over half of the events that caused patient harm were deemed preventable. Voluntary staff reporting in a quality improvement environment was found to be inferior to chart review for identifying events, but a vast improvement on the conventional incident reporting system. Most commonly implicated in the harmful or potentially harmful preventable events, and hence the best targets for prevention are dosing errors, particularly during the prescribing stage of the medication use process, and use of antibacterial agents, particularly when administered by the intravenous route.
评估住院儿童中可预防的药物相关事件的发生频率和特征,确定几种识别这些事件的方法的成效,并推荐预防重点。
在新西兰一家大学附属城市综合医院的儿科病房进行了一项为期12周的前瞻性观察队列研究。对于所有住院时间超过24小时的患者,采用多方面方法识别药物相关事件,随后由三名评审员(使用标准化评审表)根据事件类型、错误类型、用药过程阶段和可预防性进行独立分类。
有495名符合条件的研究患者,共住院520次,住院天数达3037天,在此期间共开出3160份用药医嘱。在研究期间报告的761起药物相关事件中,630起(83.3%)通过病历审查识别;111起(14.6%)通过员工自愿质量改进报告系统识别;16起(2.1%)通过家长访谈识别;4起(0.53%)通过医院同期常规事件报告系统识别。排除重复报告和与实践相关的问题后,分析共纳入696起针对研究患者的特定事件。排除无关紧要的事件(轻微违反规定和“其他”类别)后,发现大多数事件[368/399(92.2%)]是可预防的;包括38/67(56.7%)的药品不良反应、75/77(97.4%)的潜在药品不良反应以及所有255起(100%)无害用药错误。在可预防的药品不良反应和潜在药品不良反应中,最常涉及的是,事件发生率(95%置信区间):剂量不当和处方阶段——分别为每1000患者日35起(29至42起)和74起(64至84起);抗菌药物和静脉给药途径——分别为每100份用药医嘱21起(17至25起)和11起(10至13起)。
可预防的药物相关事件在儿科住院环境中普遍发生,重要的是,超过一半导致患者伤害的事件被认为是可预防的。发现在质量改进环境中员工自愿报告在识别事件方面不如病历审查,但比传统事件报告系统有了很大改进。在有害或潜在有害的可预防事件中最常涉及的,因此也是最佳预防目标的是用药剂量错误,特别是在用药过程的处方阶段,以及抗菌药物的使用,特别是静脉给药时。